Status:

UNKNOWN

Impact of Magnetic Resonance and Biomarkers for Screening for Prostate Cancer. Cost-effectiveness Analysis

Lead Sponsor:

InvestigatorUrologyIBSAL

Collaborating Sponsors:

Instituto de Investigación Biomédica de Salamanca

Conditions:

Establish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification

Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique

Eligibility:

MALE

45-75 years

Brief Summary

Objectives: To establish if there are differences between an ultrasound-guided transrectal prostate biopsy (BPTE) and a transperineal prostatic biopsy (BPTP) with and without a multiparametric Magneti...

Eligibility Criteria

Inclusion

  • Signature of informed consent prior to performing any of the specific procedures of the study
  • Age between 50 \* - 75 years (\* 45 years, if family history)
  • Patients with clinical suspicion of prostate cancer
  • Indication of a first biopsy during the study period.
  • Life expectancy greater than 10 years.

Exclusion

  • Patients previously randomized in the present study.
  • Patients submitted prior to a prostate biopsy.
  • Patients with a previous diagnosis of prostate cancer and / or previous prostate surgery.
  • Patients with a previous episode of acute prostatitis of infectious origin in the 3 months prior to inclusion in the study.
  • Patients with an active urinary tract infection and / or any previous pathology of severity in the 3 months prior to inclusion.
  • Impossibility of performing transrectal or transperineal biopsy and / or magnetic resonance.
  • Patients who have received hormonal treatment prior to androgen blockade in the 6 months prior to inclusion in the study.
  • History of other tumors.

Key Trial Info

Start Date :

March 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

628 Patients enrolled

Trial Details

Trial ID

NCT04283032

Start Date

March 1 2020

End Date

December 31 2021

Last Update

February 25 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Francisco Gómez Veiga

Salamanca, Spain, 37007